Greenlight
VTRS · Medicine & biotech

Viatris

Makes cheaper copies of medicines plus brands like Viagra and Lipitor.
Bought more
Greenlight owns 2.8 million shares of Viatris, worth about $44 million. That’s $1 of every $100 they have in stocks. Between April and June they bought 955,900 more (up 53%).
Mar 31
1,817,570
Jun 30
2,773,470

The numbers

Shares they own
2,773,470
Change since Mar 31
+955,900
+52.6%
Shares on Mar 31
1,817,570
Value on Jun 30, 2026
$44,042,703
about $44 million
Share of their money
1.1%
$1 of every $100 · 33rd of 46
Price per share on Jun 30
$15.88
Cost of the shares they added
about $15 million
at the Jun 30 price
Kind
Shares
Also owned by
No other fund we follow
More about Viatris
The value uses the price on Jun 30, 2026. The fund may have paid a different price.
Not investment advice. Holdings come from public SEC reports and the funds’ own letters, and can be up to 4½ months old. How this works